New topical erectile dysfunction drug approved via DCP in Europe
This article was originally published in Scrip
Executive Summary
Apricus Biosciences' erectile dysfunction treatment Vitaros (transdermal alprostadil) has been approved through the European decentralized procedure (DCP).